Acadian Asset Management’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,667
| Closed | -$11K | – | 1915 |
|
|
2023
Q1 | $11K | Sell |
7,667
-97,021
| -93% | -$139K | ﹤0.01% | 1684 |
|
|
2022
Q4 | $285K | Buy |
104,688
+55,892
| +115% | +$152K | ﹤0.01% | 1198 |
|
|
2022
Q3 | $191K | Buy |
48,796
+3,368
| +7% | +$13.2K | ﹤0.01% | 1223 |
|
|
2022
Q2 | $256K | Buy |
45,428
+6,439
| +17% | +$36.3K | ﹤0.01% | 1136 |
|
|
2022
Q1 | $435K | Buy |
38,989
+11,109
| +40% | +$124K | ﹤0.01% | 1036 |
|
|
2021
Q4 | $405K | Buy |
+27,880
| New | +$405K | ﹤0.01% | 1060 |
|